AstraZeneca

AstraZeneca-Covid19-Tagrisso-China
AstraZeneca's drug Tagrisso approved in China in early lung cancer
AstraZeneca's drug Tagrisso approved in China in early lung cancer
WHO-AstraZeneca-COVID19-EMA
AstraZeneca, blood clots link 'plausible but not confirmed': WHO
AstraZeneca, blood clots link 'plausible but not confirmed': WHO
AstraZeneca-COVID19-COVID vaccine-Oxford University-WHO
Link between AstraZeneca vaccine and blood clots clear: EMA official
Link between AstraZeneca vaccine and blood clots clear: EMA official
Germany-AstraZeneca-COVID19-People over 60 in Germany-COVID jab
Germany limits general use of AstraZeneca jabs to people over 60
Germany limits general use of AstraZeneca jabs to people over 60
COVID19 Vaccine-AstraZeneca-Serum Institute of India-COVID wave
Vaccine delivery from SII to lower-income economies delayed due to increased demand in India
Vaccine delivery from SII to lower-income economies delayed due to increased demand in India
AstraZeneca-COVID19-COVID vaccine-Oxford University-WHO-US trial
AstraZeneca Covid vax found 79% effective in US trial
AstraZeneca Covid vax found 79% effective in US trial
AstraZeneca-COVID19-COVID vaccine-Oxford University-WHO
It has tremendous potential: WHO on AstraZeneca jab
It has tremendous potential: WHO on AstraZeneca jab
AstraZeneca
AstraZeneca: No evidence of high blood clot risk from vaccine
AstraZeneca: No evidence of high blood clot risk from vaccine
Oxford-AstraZeneca-Covid19-vaccine
WHO recommends AstraZeneca vaccine use amid efficacy concerns
WHO recommends AstraZeneca vaccine use amid efficacy concerns
AstraZeneca
AstraZeneca's anti-diabetic drug gets nod for kidney disease in India
AstraZeneca's anti-diabetic drug gets nod for kidney disease in India
Advertisement